Lingering question from the pandemic now appears settled; the short answer is: don't ...

Holding meds does not enhance humoral immunogenicity and is associated with disease flares for patients with inflammatory arthritis.

In 1,647 Framingham adults, closer MIND diet adherence was linked to slower gray matter loss over about 12 years. See the foods, MRI data, and limitations. Virginia's new nursing home sanctions ...

A T-cell engager, blinatumomab, delivered in low doses may be beneficial in reducing disease activity and depleting synovial ...

One of the most talked about treatments for rheumatoid arthritis (RA) involves the use of disease-modifying antirheumatic drugs or DMARDs. Studies show these medications can actually halt the ...

Please provide your email address to receive an email when new articles are posted on . In two studies, no patients with rheumatoid arthritis using biological DMARDs ever had sustained DMARD-free ...

Nonadherence to DMARDs in RA varies widely, with rates from 1.5% to 100% across different studies and DMARD classes. The review identified 31 unique nonadherence measures, with indirect methods like ...

Please provide your email address to receive an email when new articles are posted on . Demographic factors were significantly associated with slower or faster initiation of b/ts DMARDs for RA.

A study looked at more than 23,600 Medicare beneficiaries with RA who had received a ≥30-day prescription of an opioid drug. Participants were grouped according to those who had been prescribed a ...

Research published in Rheumatic & Musculoskeletal Disease found that patients with rheumatoid arthritis (RA) who were taking biological disease-modifying antirheumatic drugs (DMARDs) had a 24% lower ...

No increase in disease worsening versus usual dosing, but questions remain ...

The treat-to-target approach represented a stepped-up model for chronic disease management that only became possible when the available therapies showed the potential for disease remission. The ...